s6y

Fibrocell Science, Inc.

CIK
357097
Industry
Pharmaceutical Preparations
Formerly
ISOLAGEN INC, AMERICAN FINANCIAL HOLDING INC /DE

Financials 89

  1. 10-Q Quarterly Report for period ending Sep 30, 2019
  2. 10-Q Quarterly Report for period ending Jun 30, 2019
  3. 10-Q Quarterly Report for period ending Mar 31, 2019
  4. 10-K Annual Report for period ending Dec 31, 2018
  5. 10-Q Quarterly Report for period ending Sep 30, 2018
  6. 10-Q Quarterly Report for period ending Jun 30, 2018
  7. 10-Q Quarterly Report for period ending Mar 31, 2018
  8. 10-K Annual Report for period ending Dec 31, 2017
  9. 10-Q Quarterly Report for period ending Sep 30, 2017
  10. 10-Q Quarterly Report for period ending Jun 30, 2017

All 89 financials filings

News 275

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K/A Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 275 news filings

Ownership 373

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. SC 13G Major Shareholders

All 373 ownership filings

Prospectus 113

  1. S-8 POS Post-effective amendment to a S-8 registration statement
  2. S-8 POS Post-effective amendment to a S-8 registration statement
  3. S-8 POS Post-effective amendment to a S-8 registration statement
  4. S-8 POS Post-effective amendment to a S-8 registration statement
  5. S-8 POS Post-effective amendment to a S-8 registration statement
  6. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  7. S-3 Registration statement for specified transactions by certain issuers
  8. S-1 General form of registration statement for all companies including face-amount certificate companies
  9. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  10. 424B5 Prospectus filed pursuant to Rule 424(b)(5)

All 113 prospectus filings

Proxies 40

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  3. DEFM14A Definitive proxy statement relating to a merger, acquisition, or disposition
  4. PREM14A Preliminary proxy statement relating to a merger, acquisition, or disposition
  5. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  6. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  7. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  8. DEF 14A Definitive proxy statements
  9. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  10. DEF 14A Definitive proxy statements

All 40 proxies filings

Other 184

  1. 15-12B Notice of termination of registration of a class of securities under Section 12(b)
  2. EFFECT Notice of Effectiveness
  3. EFFECT Notice of Effectiveness
  4. EFFECT Notice of Effectiveness
  5. EFFECT Notice of Effectiveness
  6. EFFECT Notice of Effectiveness
  7. EFFECT Notice of Effectiveness
  8. 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
  9. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  10. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing

All 184 other filings